Allyl(2S)-1-(3-bromo-3a,4,6,6a-tetrahydropyrrolo[3,4-d]isoxazol-5-yl)-4-methyl-1-oxopentan-2-ylcarbamate

ID: ALA3629339

Chembl Id: CHEMBL3629339

PubChem CID: 122194221

Max Phase: Preclinical

Molecular Formula: C15H22BrN3O4

Molecular Weight: 388.26

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  C=CCOC(=O)N[C@@H](CC(C)C)C(=O)N1CC2ON=C(Br)C2C1

Standard InChI:  InChI=1S/C15H22BrN3O4/c1-4-5-22-15(21)17-11(6-9(2)3)14(20)19-7-10-12(8-19)23-18-13(10)16/h4,9-12H,1,5-8H2,2-3H3,(H,17,21)/t10?,11-,12?/m0/s1

Standard InChI Key:  VGSULLNOTWOPAJ-CXQJBGSLSA-N

Alternative Forms

1. Parent:

   

   ALA3629339

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 388.26

Molecular Weight (Monoisotopic): 387.0794

AlogP: 1.88

#Rotatable Bonds: 6

Polar Surface Area: 80.23

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.15

CX Basic pKa: ┄

CX LogP: 1.94

CX LogD: 1.94

Aromatic Rings: ┄

Heavy Atoms: 23

QED Weighted: 0.71

Np Likeness Score: -0.45

References

1. Ettari R, Pinto A, Previti S, Tamborini L, Angelo IC, La Pietra V, Marinelli L, Novellino E, Schirmeister T, Zappalà M, Grasso S, De Micheli C, Conti P..  (2015)  Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation.,  23  (21): [PMID:26432608] [10.1016/j.bmc.2015.09.029]

Source

Source(1):

• Scientific Literature